| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 2,124,599 | 2,174,112 | 1,902,297 | 2,153,287 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 2,124,599 | 2,174,112 | 1,902,297 | 2,153,287 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,700,781 | 1,795,058 | 1,729,493 | 1,659,586 | | Non Recurring |
-
|
-
| (19,734) |
-
| | Others | 420 | 420 | 420 | 420 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 423,398 | 378,634 | 192,118 | 493,281 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| (52,552) | | Earnings Before Interest And Taxes | 423,398 | 378,634 | 192,118 | 539,450 | | Interest Expense | 65,441 | 124,112 | 163,401 | 151,018 | | Income Before Tax | 357,957 | 254,522 | 28,717 | 388,432 | | Income Tax Expense | 51,205 | 30,702 | 41,164 | 58,715 | | Minority Interest |
-
|
-
| 66 |
-
| | | | Net Income From Continuing Ops | 237,851 | 244,373 | (1,212,869) | 371,636 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 237,851 | 244,373 | (1,212,869) | 371,636 | | Preferred Stock And Other Adjustments |
-
| (32,500) | (2,984) | (43,661) | | | Net Income Applicable To Common Shares | $237,851 | $211,873 | ($1,215,853) | $327,975 |
|
7.87% Nasdaq 
Income Statement
